Literature DB >> 20972239

Intestinal Bacteroides species associated with coeliac disease.

Ester Sánchez1, Ester Donat, Carmen Ribes-Koninckx, Miguel Calabuig, Yolanda Sanz.   

Abstract

AIMS: To characterise the predominant species of bacterial populations associated with duodenal biopsies of paediatric patients with active and treated coeliac disease.
METHODS: 20 biopsy specimens from patients with active coeliac disease, 12 from patients with treated coeliac disease, and eight from age-matched controls were evaluated for comparative purposes. Bacteroides, Bifidobacterium and lactic acid bacteria (LAB) populations were analysed by PCR-denaturing gradient gel electrophoresis using group-specific primers.
RESULTS: Bacteroides diversity was higher in biopsy specimens from controls than in those from patients with active and treated coeliac disease. Bacteroides distasonis, Bacteroides fragilis/Bacteroides thetaiotaomicron, Bacteroides uniformis and Bacteroides ovatus were more abundant in controls than in patients with coeliac disease (p<0.05). Bacteroides vulgatus was more frequently detected in controls than in patients with treated coeliac disease (p<0.01). Bacteroides dorei was more common in patients with active coeliac disease than in those with treated coeliac disease and control children (p<0.01). Bifidobacterium diversity was higher in patients with coeliac disease than in controls. Bifidobacterium adolescentis and Bifidobacterium animalis subsp lactis were more prevalent in patients with active coeliac disease than in patients with treated coeliac disease and control children. A higher LAB diversity was found in patients with treated coeliac disease and controls than in patients with active coeliac disease. Weissella spp and Lactobacillus fermentum were more frequently detected in patients with treated coeliac disease than in controls and patients with active coeliac disease.
CONCLUSIONS: Bacteroides, Bifidobacterium and LAB populations in the duodenum of Spanish children with typical coeliac disease (active and treated) and controls differ in diversity and species composition; this could contribute to features of the disease.

Entities:  

Mesh:

Year:  2010        PMID: 20972239     DOI: 10.1136/jcp.2010.076950

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  37 in total

1.  Salivary microbiota and metabolome associated with celiac disease.

Authors:  Ruggiero Francavilla; Danilo Ercolini; Maria Piccolo; Lucia Vannini; Sonya Siragusa; Francesca De Filippis; Ilaria De Pasquale; Raffaella Di Cagno; Michele Di Toma; Giorgia Gozzi; Diana I Serrazanetti; Maria De Angelis; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

Review 2.  Non-dietary forms of treatment for adult celiac disease.

Authors:  Hugh James Freeman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

Review 3.  Gut microbes and adverse food reactions: Focus on gluten related disorders.

Authors:  Heather J Galipeau; Elena F Verdu
Journal:  Gut Microbes       Date:  2014

4.  On the role of gut bacteria and infant diet in the development of autoimmunity for type 1 diabetes. Reply to Hänninen ALM and Toivonen RK [letter].

Authors:  Austin G Davis-Richardson; Eric W Triplett
Journal:  Diabetologia       Date:  2015-07-24       Impact factor: 10.122

5.  Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin.

Authors:  Femke-Anouska Heinsen; Henrik Knecht; Sven C Neulinger; Ruth A Schmitz; Carolin Knecht; Tanja Kühbacher; Philip C Rosenstiel; Stefan Schreiber; Anette K Friedrichs; Stephan J Ott
Journal:  Gut Microbes       Date:  2015-07-04

Review 6.  Engineering the Microbiome: a Novel Approach to Immunotherapy for Allergic and Immune Diseases.

Authors:  Nan Shen; Jose C Clemente
Journal:  Curr Allergy Asthma Rep       Date:  2015-07       Impact factor: 4.806

7.  Dietary Gluten as a Conditioning Factor of the Gut Microbiota in Celiac Disease.

Authors:  Karla A Bascuñán; Magdalena Araya; Leda Roncoroni; Luisa Doneda; Luca Elli
Journal:  Adv Nutr       Date:  2020-01-01       Impact factor: 8.701

Review 8.  Celiac disease: should we care about microbes?

Authors:  Alberto Caminero; Elena F Verdu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-06-12       Impact factor: 4.052

9.  Lysozyme-rich mucus metaplasia in duodenal crypts supersedes Paneth cells in celiac disease.

Authors:  Carlos A Rubio
Journal:  Virchows Arch       Date:  2011-07-18       Impact factor: 4.064

10.  Non-lethal growth inhibition by arresting the starch utilization system of clinically relevant human isolates of Bacteroides dorei.

Authors:  Anthony D Santilli; Jordan T Russell; Eric W Triplett; Kristi J Whitehead; Daniel C Whitehead
Journal:  Medchemcomm       Date:  2019-07-05       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.